← Back to Bills
HR 7312118th CongressFailed / ExpiredHouse

EPCS 2.0 Act

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Jul 21, 2025
Latest Action Date
Dec 17, 2024

Latest Action

Referred to the Subcommittee on Health.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The EPCS 2.0 Act is a legislative proposal introduced in the 118th Congress aimed at addressing issues related to electronic prescribing of controlled substances (EPCS). The bill was referred to the Subcommittee on Health but ultimately failed or expired without further action. Specific details about the bill's provisions, objectives, or mechanisms are not available in the provided source data.

Bottom Line

The EPCS 2.0 Act sought to update or improve electronic prescribing of controlled substances but did not advance beyond initial referral and expired without enactment.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill is focused on the health policy area, specifically electronic prescribing of controlled substances.
  • It was introduced in the House of Representatives during the 118th Congress.
  • The bill was referred to the Subcommittee on Health on December 17, 2024, but no further legislative progress is recorded.
Who Benefits?

['Healthcare providers who use electronic prescribing systems', 'Patients requiring controlled substances prescriptions', 'Health IT vendors and electronic prescribing software developers', 'Regulatory agencies overseeing controlled substance prescriptions']

Potential Concerns

['Lack of publicly available full text limits understanding of implementation requirements and enforcement mechanisms.', 'Potential costs associated with updating or maintaining electronic prescribing systems are unknown.', 'Oversight and authority provisions cannot be assessed due to missing bill text.', 'The failure or expiration of the bill indicates possible challenges in legislative support or consensus.']

Political Context

The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health. No further actions were taken, and the bill expired, indicating it did not gain sufficient traction for passage. The absence of a summary or full text in the public record limits detailed analysis of its legislative intent or policy specifics.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

['If enacted, the bill could have influenced the adoption and security standards of electronic prescribing systems for controlled substances.', 'Potential improvements in prescribing practices might have affected healthcare delivery and regulatory compliance.', 'Failure to pass may delay updates or reforms in electronic prescribing technology and related health IT infrastructure.']

GovScope Watchdog Notes

The lack of publicly available bill text and summary limits transparency and public understanding of the EPCS 2.0 Act's intended policy changes. Monitoring legislative progress and ensuring timely publication of bill details are essential for informed public discourse and oversight.

Passage Likelihood: LowConfidence: 60%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready